-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Protagenic Therapeutics, Inc.\new quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q2 2010 to Q2 2024.
- Protagenic Therapeutics, Inc.\new Weighted Average Number of Shares Outstanding, Diluted for the quarter ending June 30, 2024 was 4.44M shares, a 2.59% increase year-over-year.
- Protagenic Therapeutics, Inc.\new annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 4.34M shares, a 0.62% increase from 2022.
- Protagenic Therapeutics, Inc.\new annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 4.32M shares.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)